• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ENDOBON® XENOGRAFT GRANULES 0.5ML; BONE GRAFTING MATERIAL, SYNTHETIC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ENDOBON® XENOGRAFT GRANULES 0.5ML; BONE GRAFTING MATERIAL, SYNTHETIC Back to Search Results
Model Number ROX05
Device Problem Failure to Osseointegrate (1863)
Patient Problem Inadequate Osseointegration (2646)
Event Date 10/13/2018
Event Type  Injury  
Manufacturer Narrative
(b)(4).Report source, foreign: event occurred in (b)(6).The device was not returned to the manufacturer.Therefore it could not be analyzed.The review of the device manufacturing quality record indicates that 694 products endobon xenograft granules 0.5ml, reference (b)(4) batch u0153300 were manufactured on 12 november 2014.The device manufacturing quality record indicates that the released product met all requirements to perform as intended.No non conformity or deviation was observed which could be linked to the event described in the complaint.The investigation is in progress.Once the investigation has been completed, a follow-up mdr will be submitted.If any further information is found which would change or alter any conclusions or information, a supplemental will be filed accordingly.
 
Event Description
It was reported by the doctor the non integration of endobon.
 
Event Description
It was reported by the doctor non integration of endobon.Customer requests compensation.Additional information received on (b)(6) 2020 explain that curettage has been performed.
 
Manufacturer Narrative
(b)(4).This follow-up report is being submitted to relay additional information and correction.The following section has been updated : b3, b4, b5, e1, e3, g4, h2, h6 and h10.The product analysis can't be performed as the product was not returned.The device manufacturing quality record indicate that the released product met all requirements to perform as intended.A complaint extract was done regarding non integration: - 10 complaints have been recorded on endobon xenograft granules 0.5ml, reference (b)(4), from 1 (b)(6) 2020.- 1 complaint has been recorded on endobon xenograft granules 0.5ml, reference (b)(4), batch u0153300.According to available data, the root cause of the event can¿t be determined.If any further information is found which would change or alter any conclusions or information, a supplemental will be filed accordingly.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ENDOBON® XENOGRAFT GRANULES 0.5ML
Type of Device
BONE GRAFTING MATERIAL, SYNTHETIC
MDR Report Key9472149
MDR Text Key171977684
Report Number3006946279-2019-00547
Device Sequence Number1
Product Code LYC
UDI-Device Identifier03599870091258
UDI-Public(01)03599870091258
Combination Product (y/n)N
PMA/PMN Number
K110449
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional
Type of Report Initial,Followup
Report Date 03/11/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/16/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Expiration Date09/30/2017
Device Model NumberROX05
Device Catalogue NumberROX05
Device Lot NumberU0153300
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Date Manufacturer Received02/25/2020
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured11/12/2014
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-